CenterWatch

Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Nephrology | Urology
Disease Category: Prostate Disorders
Location: United States, CA

Clinical Trial Details

Overview

Research Study Summary

Enlarged Prostate Study

Purpose

A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 weeks in Men with Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)

Patient Inclusion Criteria:

  • Men 45+
  • PSA > 1.4 and < 10ng/mL
  • If hyperlipidemic, on stable statin treatment for at least two months

Patient Exclusion Criteria:

  • Proscar or Avodart within 6 months
  • Alpha blockers, herbal preparations, overactive bladder treatment within 1 month
  • E.D. treatment within 1 month
  • Testosterone replacement therapy within 1 month
  • Prior surgical or other invasive prostate procedures
  • Active cardiovascular disease (recent MI, unstable angina, stroke, TIA within 6 months)
  • Prostate, breast, or other cancer
  • Deep vein thrombosis

To Learn more

CW ID:164504
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Phase
2
Gender
Male
Age
45 and up
Overall Status
Recruiting
Duration
24 Weeks
Facility Type
N/A

Contact

West Coast Clinical Research
5525 Etiwanda Ave., Suite 202
Tarzana, CA 91356
Phone: 818-776-0820, Ext. 101
Fax: 818-776-1269

View Map

Research Center Information: West Coast Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.